University of Missouri - Columbia
Columbia, Missouri, 65211, United States
Location status: Recruiting
Location contact
Brett Froeliger, PhD
CONTACT
Madhura Athreya, MS
CONTACT
NCT Number: NCT03713424
This research study is looking into the effects of clavulanic on smoking behavior in adult cigarette smokers. The primary study hypothesis is that, compared to placebo, clavulanic acid will reduce smoking over the course of the study.
Interested in participating?
Request Info18 year–65 year
All sexes
Interventional
Phase 2
Columbia, Missouri, 65211, United States
Location status: Recruiting
Brett Froeliger, PhD
CONTACT
Madhura Athreya, MS
CONTACT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Entry criteria:
Inclusion criteria
all subjects:
Exclusion criteria
all subjects:
Beta lactamase inhibitor for smoking cessation
placebo
Time frame: 5 days
Biochemical smoking assessment (breath carbon monoxide) at each study visit.
Time frame: 5 Days
Number of reported side effects
Time frame: 4 days
Measure the effects of Clavulanic Acid on fMRI BOLD response to images (change from baseline to end of study) while participants undergo functional magnetic resonance imaging
Time frame: 4 days
Measure the effects of Clavulanic Acid on resting-state functional connectivity (change from baseline to end of study) while participants undergo functional magnetic resonance imaging.
Contact information is provided by the study sponsor or research team.
Brett E Froeliger, PhD
CONTACT
Madhura Athreya, MS
CONTACT
University of Missouri-Columbia
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07425119
Behavior, Chemically-Induced Disorders
Durham, North Carolina, United States
View Trial DetailsNCT06239350
Behavior, Chemically-Induced Disorders
Charleston, South Carolina, United States
View Trial DetailsNCT05452772
Behavior, Chemically-Induced Disorders
Birmingham, Alabama, United States
View Trial DetailsNCT06688539
Behavior, Chemically-Induced Disorders
Charleston, South Carolina, United States
View Trial Details